PL2707032T3 - Wszczepialne urządzenie polimerowe do przedłużonego uwalniania sufentanylu - Google Patents

Wszczepialne urządzenie polimerowe do przedłużonego uwalniania sufentanylu

Info

Publication number
PL2707032T3
PL2707032T3 PL12723023T PL12723023T PL2707032T3 PL 2707032 T3 PL2707032 T3 PL 2707032T3 PL 12723023 T PL12723023 T PL 12723023T PL 12723023 T PL12723023 T PL 12723023T PL 2707032 T3 PL2707032 T3 PL 2707032T3
Authority
PL
Poland
Prior art keywords
sufentanil
sustained release
polymeric device
implantable polymeric
implantable
Prior art date
Application number
PL12723023T
Other languages
English (en)
Inventor
Herriot TABUTEAU
Original Assignee
Antecip Bioventures Ii Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antecip Bioventures Ii Llc filed Critical Antecip Bioventures Ii Llc
Publication of PL2707032T3 publication Critical patent/PL2707032T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL12723023T 2011-05-10 2012-05-10 Wszczepialne urządzenie polimerowe do przedłużonego uwalniania sufentanylu PL2707032T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161484222P 2011-05-10 2011-05-10
EP12723023.3A EP2707032B1 (en) 2011-05-10 2012-05-10 Implantable polymeric device for sustained release of sufentanil
PCT/US2012/037373 WO2012154986A1 (en) 2011-05-10 2012-05-10 Implantable polymeric device for sustained release of sufentanil

Publications (1)

Publication Number Publication Date
PL2707032T3 true PL2707032T3 (pl) 2020-03-31

Family

ID=46147751

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12723023T PL2707032T3 (pl) 2011-05-10 2012-05-10 Wszczepialne urządzenie polimerowe do przedłużonego uwalniania sufentanylu

Country Status (7)

Country Link
US (2) US20120288551A1 (pl)
EP (1) EP2707032B1 (pl)
DK (1) DK2707032T3 (pl)
ES (1) ES2743906T3 (pl)
PL (1) PL2707032T3 (pl)
PT (1) PT2707032T (pl)
WO (1) WO2012154986A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2276473T1 (sl) 2008-04-18 2017-02-28 Intec Pharma Ltd. Gastro retencijsko dajanje zdravila karbidope/levodope
GB201317641D0 (en) 2013-10-05 2013-11-20 Chowdhury Dewan F H Novel solid dosage form

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069307A (en) * 1970-10-01 1978-01-17 Alza Corporation Drug-delivery device comprising certain polymeric materials for controlled release of drug
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5919473A (en) * 1997-05-12 1999-07-06 Elkhoury; George F. Methods and devices for delivering opioid analgesics to wounds via a subdermal implant
US6541021B1 (en) * 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
US7186260B2 (en) * 1999-04-29 2007-03-06 Hyson Morton I Medicated wrap
US6632217B2 (en) * 2001-04-19 2003-10-14 Microsolutions, Inc. Implantable osmotic pump
WO2003000156A1 (en) * 2001-06-22 2003-01-03 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
JP4668611B2 (ja) * 2002-05-31 2011-04-13 タイタン ファーマシューティカルズ インコーポレイテッド ブプレノルフィンの持続放出のための埋め込み型ポリマー製装置
US8779090B2 (en) * 2007-02-26 2014-07-15 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of heart failure and other disorders
US8470360B2 (en) * 2008-04-18 2013-06-25 Warsaw Orthopedic, Inc. Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
US20090263489A1 (en) * 2008-04-18 2009-10-22 Warsaw Orthopedic, Inc. Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
US20110027331A1 (en) * 2009-07-29 2011-02-03 Warsaw Orthopedic, Inc. An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation
US9017312B2 (en) * 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US20110106110A1 (en) * 2009-10-30 2011-05-05 Warsaw Orthopedic, Inc. Devices and methods for implanting a plurality of drug depots having one or more anchoring members

Also Published As

Publication number Publication date
PT2707032T (pt) 2019-09-17
WO2012154986A1 (en) 2012-11-15
DK2707032T3 (da) 2019-09-09
ES2743906T3 (es) 2020-02-21
US20120288551A1 (en) 2012-11-15
EP2707032A1 (en) 2014-03-19
EP2707032B1 (en) 2019-06-26
US20170014515A1 (en) 2017-01-19

Similar Documents

Publication Publication Date Title
IL227530A (en) A transplantable device for controlled release of a low-solubility drug
EP2571496A4 (en) CONTROLLED RELEASE OF MEDICINE FROM DENIMERS
EP2786713A4 (en) MEDICAL DEVICE
PT2600812T (pt) Aparelho para tratar um olho
AU335676S (en) Stimulation device
EP2575702A4 (en) orthotic device
EP2664268A4 (en) MEDICAL DEVICE
EP2596765A4 (en) STENT DEVICE
EP2735258A4 (en) MEDICAL DEVICE
SI2523722T1 (sl) Naprava za elektrostimulacijo
GB201105243D0 (en) An implant
AU335189S (en) Stimulation device
PT2904995T (pt) Dispositivo ortopédico
PL3023120T3 (pl) Aparaty do podawania leków przez skórę
GB2492203B (en) Anchor device
EP2760502A4 (en) DEVICES AND METHODS FOR INSTALLATION FOR GASTROINTESTINAL IMPLANTS
EP2682074A4 (en) ENDOPROTHESIS DEVICE
GB201111100D0 (en) Apparatus for ostomy devices
GB201008448D0 (en) Transdermal device
EP2786938A4 (en) DRUGS OUTPUT DEVICE
ZA201306602B (en) Device for making artificial nails
GB201113000D0 (en) Stimulation device
GB201107845D0 (en) Medical device
PL2707032T3 (pl) Wszczepialne urządzenie polimerowe do przedłużonego uwalniania sufentanylu
GB201105856D0 (en) Restraint device